The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
Medical experts point to a growing body of research linking energy drinks to liver injury
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Subscribe To Our Newsletter & Stay Updated
